You can also register below to be contacted by our staff to determine if you qualify and schedule your screening visit!

Name *
BHV3000-305 Print Ads (version 2.0).jpg

Do you experience between 4 and 18 migraines per month?

If so, you may qualify for a clinical trial investigating a new treatment to prevent migraines.

If you qualify for this study you will be compensated for your time and travel.

The purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.